Pancreatic ductal adenocarcinoma Trials in Chicago, United States
Conditions / Pancreatic ductal adenocarcinoma / Chicago, United States
Clinical trials for Pancreatic ductal adenocarcinoma investigate a range of treatment strategies and patient populations.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07076121 | A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) | RECRUITING | — |
| NCT04042480 | A Study of SGN-CD228A in Advanced Solid Tumors | TERMINATED | PHASE1 |
| NCT04025216 | A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers | TERMINATED | PHASE1 |
| NCT04851119 | Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT01658943 | Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy | COMPLETED | PHASE2 |
| NCT06147037 | A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours | RECRUITING | — |
| NCT03794128 | A Study of Personalized Neoantigen Cancer Vaccines | COMPLETED | — |
| NCT01013649 | Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery | COMPLETED | PHASE3 |
| NCT06607185 | A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors | ACTIVE_NOT_RECRUITING | — |
| NCT04970056 | Pancreatic Cancer Early Detection Consortium | RECRUITING | — |